Literature DB >> 25643174

Self-binding peptides: folding or binding?

Chao Yang1, Shilei Zhang, Ping He, Congcong Wang, Jian Huang, Peng Zhou.   

Abstract

Self-binding peptides (SBPs) represent those short peptide segments within monomeric proteins to fulfill their biological functions by dynamically binding to/unbinding from their target domains in the same monomers. They are frequently found in disordered or unstructured regions of proteins that are now known to be not simply helices, loops, or linkers and adopt a well-defined structure upon binding. In this study, we systematically explored the structural basis, energy landscape, and thermodynamic properties of SBP-mediated biological mechanisms by dissecting dynamic interactions of SBPs with their cognate targets. In order to identify whether the formation of the SBP-target bound state is naturally a folding or a binding, we carried out atomistic molecular dynamics (MD) simulations to investigate both the native bound state of eight representative SBPs in complex with their cognate domains and the same bound state but where the SBPs were split artificially from the domains in primary sequence. Results showed that the splitting did not influence essentially the interaction behavior of SBPs with their target domains, suggesting that the SBP-domain interaction is almost a binding phenomenon, although the polypeptide linker between the SBP and the domain seems to facilitate the interaction. In addition, the sequence pattern of SBPs is very similar to those of short linear motifs (SLiM) found in many protein-binding peptides where few key residues contribute predominantly to protein-peptide recognition. All of the above comes together to suggest that the SBP is a novel biomolecular phenomenon spanning between folding and binding.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25643174     DOI: 10.1021/ci500522v

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  13 in total

1.  Electrostatic mechanism of V600E mutation-induced B-Raf constitutive activation in colorectal cancer: molecular implications for the selectivity difference between type-I and type-II inhibitors.

Authors:  Tie Liu; Zhaoshun Wang; Peng Guo; Na Ding
Journal:  Eur Biophys J       Date:  2018-09-14       Impact factor: 1.733

2.  Rational redesign of a cation···π···π stacking at cardiovascular Fbw7-Skp1 complex interface and its application for deriving self-inhibitory peptides to disrupt the complex interaction.

Authors:  Jing Zhou; Yao-Sheng Wang
Journal:  J Mol Model       Date:  2017-09-26       Impact factor: 1.810

3.  Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer.

Authors:  Jianchun Zhang; Tao Ji
Journal:  J Mol Model       Date:  2016-12-05       Impact factor: 1.810

4.  Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.

Authors:  Min Han; Dongdong Sun
Journal:  J Comput Aided Mol Des       Date:  2019-06-15       Impact factor: 3.686

5.  Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist.

Authors:  Caleigh M Azumaya; Emily A Linton; Caitlin J Risener; Terunaga Nakagawa; Erkan Karakas
Journal:  J Biol Chem       Date:  2020-01-08       Impact factor: 5.157

6.  Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia.

Authors:  Xiangxiang Shi; Jun Zheng; Tingting Yan
Journal:  J Mol Model       Date:  2018-03-02       Impact factor: 1.810

7.  Grafting, Stripping and Stapling of Helical Peptides from the Dimerization Interface of ONFH-Related Bone Morphogenetic Protein-2.

Authors:  Wenqi Song; Kunzheng Wang; Wei Wang; Pei Yang; Xiaoqian Dang
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

8.  Structural Identification and Systematic Comparison of Phorbol Ester, Dioleoylglycerol, Alcohol and Sevoflurane Binding Sites in PKCδ C1A Domain.

Authors:  Lijie Shi
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

9.  Rational design of type-IA receptor-derived cyclic peptides to target human bone morphogenic protein 2.

Authors:  Xiaohua Fan; Hai Xia; Xiaoyun Liu; Benying Li; Jun Fang
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

10.  Electrostatic explanation of D1228V/H/N-induced c-Met resistance and sensitivity to type I and type II kinase inhibitors in targeted gastric cancer therapy.

Authors:  Zhen Xu; Pingping Hu; Dong Fang; Lingna Ni; Jianzhong Xu
Journal:  J Mol Model       Date:  2019-01-03       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.